Seagate Slides Again as Options Sentiment Turns and Shorts Rebuild

Seagate Technology Holdings has dropped another 9.2% over the past week to $606.38, extending a bruising month that has now taken the stock down nearly 29% from its recent highs, while closest peers WDC and SNDK fell 8.8% and 13.7% respectively over the same stretch, suggesting sector-wide pressure rather than a company-specific break.

The most striking development this week is in options, where positioning has shifted sharply less defensive. The put/call ratio dropped to 1.54, almost 2.4 standard deviations below its 20-day average of 1.91. That is a significant move: through September and into October the ratio was consistently above 2.0, peaking near 2.4, reflecting heavy demand for downside protection. The unwinding of that hedging activity even as the stock continues to fall is unusual. It may reflect options expiries clearing out old put positions, or it could indicate that the investors who wanted protection have already paid for it. Either way, the options market now looks meaningfully less braced for further declines than it did a month ago. The 52-week low on the PCR is 0.94, so there is room to unwind further. Separately, short interest has been creeping back up. It rose roughly 1.7% over the week to 3.7% of the free float, around 8 million shares, after a sharp drop in mid-October from above 9 million. The rebuild is gradual rather than aggressive, and the lending market remains extremely loose: availability is running at over 7,000% of current short interest, meaning the borrow pool is almost entirely idle, and the cost to borrow at 0.48% is low. There is no pressure building in the lending market that would concern an existing short.

The Street's view remains constructive but target prices have been coming down hard. Following the October 27 results, most of the analyst community maintained positive ratings while trimming numbers. UBS held Neutral and cut to $750. Citigroup kept Buy but lowered to $1,050 from $1,300. Wells Fargo trimmed to $820 from $865 while holding Overweight. Morgan Stanley, also Overweight, moved to $1,148 from $1,200. With 18 buy ratings against 4 holds and a mean target of $1,033, the consensus implies roughly 70% upside from current levels. That is an unusually wide gap, and it reflects a Street that is not abandoning the thesis but is openly uncertain about the timeline. Valuation has compressed sharply: the price-to-earnings multiple has fallen around 7.6 points over the past 30 days, and price-to-book is down about 8 points over the same period, resetting Seagate to levels that may draw fresh interest on a longer view. EV/EBITDA has contracted as well, now at 8.4x. Factor scores are mixed: EPS momentum ranks in the 96th percentile over 30 days and the 89th over 90 days, reflecting the strong earnings track record, but the EV/EBIT ranking sits at the 38th percentile, keeping value-oriented buyers on the sidelines.

CEO William Mosley sold just under 5,000 shares on November 2 at prices ranging from roughly $618 to $644, totalling approximately $2.6 million. All transactions were executed under a pre-arranged 10b5-1 plan. That classification matters: plan-based sales are scheduled well in advance and carry far less informational weight than a discretionary sale. Over the past 90 days, net insider selling has totalled around $19.4 million across 31,887 net shares. The aggregate figure is worth noting, but the 10b5-1 framing applies to the visible recent activity. Among institutional holders, Vanguard Capital Management and BlackRock remain the two largest disclosed positions, each around 6.6% to 6.9% of shares. Capital Research Global Investors and JPMorgan have both filed reduced stakes since mid-2025. No 13D activist is on the register, and no holder is pushing for strategic change.

The alt data coverage for Seagate does not include any measured leading indicator against its reported figures, so it adds limited forward colour. What it does show is that retail attention is elevated: the Wikipedia and ORTEX page-view signal is running at a z-score of 2.0 against its own trailing 90-day history, the highest attention reading in the available window. That is likely a function of the sharp share price move drawing casual observers rather than a signal about fundamentals. On buybacks, the most recent fact from SEC EDGAR XBRL filings shows Q2 buyback spend was the largest for any second quarter in three years at $30 million, though Q1 saw share repurchases fall 50% year-on-year.

The next earnings date is January 25. Between now and then, the stock is navigating a 70% gap between current price and consensus target, a PCR that has just moved from extreme defensiveness to something closer to neutral, and a short position that is rebuilding slowly in a market where borrowing is cheap and abundant. What closes that target gap, or widens it further, is the question the next quarterly print will have to answer.